The aim of this study was to investigate the correlation between the histologic invasiveness (histologic stage) and various cell proliferation activity assays (quantity of argyrophil proteins associated with nucleolar organizer regions [AgNORs], mitotic activity, MIB1 [Ki67] immunohistochemical detection) for predicting the biologic behavior of malignant canine mammary tumors. Sixty specimens from malignant canine mammary tumors with no distant metastases (M0) at surgery were selected, and follow-up data were collected over a 2-year period. The histologic invasiveness was graded by histologic stage (stage 0 ϭ tumors without stromal invasion; stage I ϭ tumors with stromal invasion; stage II ϭ tumors with neoplastic emboli in vessels), and the proliferative indices were expressed as MIB1 index (the percentage of nuclear area immunohistochemically stained by MIB1 antibody), mitotic index (the number of mitoses per 1,000 neoplastic cells), and AgNOR index (the ratio between mean AgNOR area of tumor cells and the mean AgNOR area of fibroblasts/lymphocytes). The measures of proliferative activity were compared among groups with different histologic stages, and the influence of different prognostic variables (histologic stage, AgNOR index, mitotic index, MIB1 index) on survival time was evaluated. A significant difference in the proliferation patterns was recorded between the different histologic stages for the mitotic index (P ϭ 0.0006) and MIB1 index (0.0013). Among the different parameters considered, histologic stage (P Ͻ 0.05), AgNOR index (P ϭ 0.0291), and MIB1 index (P ϭ 0.014) revealed a significant association with prognosis in univariate analysis. AgNOR index for 1-year survival and histologic stage for 2-year survival were the most significant parameters influencing survival, as determined by multiple nonlinear logistic regression.
Mammary tumors are very common in the female dog, and their malignant counterparts account for 40-50% of all histologically diagnosed neoplasms. 18 Histopathologic and clinical aspects of these tumors have been widely reviewed; [3] [4] [5] 18, 24 nevertheless, the presence of considerable variations in the biologic behavior, even among histologically malignant tumors, often does not allow an accurate prognosis using microscopic examination alone.
In previous years, many efforts have been made to find correlations among clinical staging, different histomorphologic criteria, and clinical prognosis. 3, 4, 11, 12, 14, 18, 19, 24 Unfortunately, no reliable criteria have been established, although tumor size and histologic staging or invasiveness seem to have a high prognostic value. 4, 12, 18, 22 Assessment of cell proliferation has been useful for the evaluation of biologic behavior and potential malignancy of tumors. 15, 29, 32 In veterinary oncology, the recent introduction of methods applicable to formalin-fixed, paraffin-embedded tissues (Ki67 and proliferating cell nuclear antigen [PCNA] immunohistochemical detection, quantitation of argyrophil proteins associated with nucleolar organizer regions [AgNORs]) has allowed the evaluation of proliferative activity in situ, thus increasing interest in diagnostic and prognostic applications.
The immunohistochemical identification of antigens specific to dividing (cycling) cells by monoclonal antibodies directed against Ki67 and PCNA offers a good approach to evaluation of the growth fraction 20 (the ratio of cycling cells to total cells in the population). 32 The monoclonal antibody clone MIB1 a (mouse anti-human proliferation antigen expressed in G2/M phases of the cell cycle) recognizes on formalin-fixed, paraffin-embedded sections the same antigen as Ki67 recognizes on frozen sections. The evaluation of AgNOR quantity, which is strictly related to cell duplication rate, 31 is also thought to be a useful and simple proliferation marker. Although several studies have shown a certain relevance of the parameters of cellular proliferation, their prognostic usefulness in canine mammary tumors is widely debated. 6, 10, 21, 27, 28 The purpose of this study was to investigate the correlation between the histologic invasiveness (histologic stage) and 3 parameters assessing cell proliferative activity (AgNOR, mitotic index, MIB1 index) for predicting the biologic behavior of malignant canine mammary tumors.
Materials and methods

Dogs and samples
Sixty tissue samples were obtained from female dogs with malignant primary mammary tumors. All the dogs underwent surgery at the University Clinic of Veterinary Surgery (Bologna, Italy) and in private clinics between 1992 and 1997.
Before surgery and every 2 mo over a 2-yr period, radiographs of the thorax and ultrasonograms of the spleen, liver, and kidneys were obtained. None of the dogs had distant metastases (M0) at surgery, and follow-up data were collected over this period and expressed as survival time (the time between surgery and death due to the tumor, either spontaneous death or euthanasia). After 24 mo of follow-up, the animals still alive were considered assessed and those that had died were considered nonassessed.
The tissue samples were immediately fixed in 10% buffered formalin and routinely processed. Histologic diagnoses were made on hematoxylin and eosin-stained slides according to a published method, 16 and histologic grade of invasion was determined by a single examiner (CB) according to a system previously proposed: 14 stage 0 ϭ tumors without stromal invasion; stage I ϭ tumors with stromal invasion; and stage II ϭ tumors with neoplastic emboli in vessels. For each tumor, 3 4-m-thick consecutive sections were used, 1 each for AgNOR staining, toluidine blue staining, and MIB1 immunohistochemistry.
AgNOR method
Sections were stained according to the protocol of the standardized AgNOR method. 1 The dewaxed sections were immersed in citrate buffer at pH 6.0 and heated for 4 5-min periods in a microwave oven at 750 W. After cooling to room temperature (RT), the sections were washed in doubledistilled water and stained with a fresh solution of 1 volume 2% gelatin in 1% aqueous formic acid and 2 volumes 50% silver nitrate at 37 C for 14 min in the dark. Following a thorough rinsing with ultrapure water, the sections were washed in distilled water (DW), dehydrated, and mounted in Canada-Balsam. b
Toluidine blue stain
A previously described modification was used. 8 The sections were dewaxed in toluene, rehydrated, and then hydrolyzed in 5 N HCl for 20 min at RT, rinsed twice (5 min each) in DW, and immersed for 10 min in a solution of 0.5 g toluidine blue O in 100 ml of bleach solution (90 ml of double-distilled water, 5 ml 1 N HCl, 5 ml 10% sodium metabisulphite). The sections were then immersed twice (1 min each) in bleach solution, rinsed in DW, dehydrated, and mounted with dibutylphthalate-xylene.
MIB1 immunohistochemistry
The sections were dewaxed in toluene and rehydrated in a graded acetone series (acetone 100%: 2 immersions of 10 min each; acetone 70%: 10 min; acetone 50%: 10 min). Endogenous peroxidase was blocked by immersion in 3% hydrogen peroxide for 30 min. Sections were then rinsed in Tris buffer, immersed in citrate buffer (2.1 g citric acid monohydrate/liter DW), pH 6.0, incubated for 4 5-min periods in a microwave oven at 750 W, and allowed to cool down to RT (approximately 20 min). The primary antibody, clone MIB1 a (mouse anti-human, diluted 1:30) was applied for 60 min and was followed by a commercial streptavidinbiotin-peroxidase technique. c In negative control sections, the primary antibody was replaced with phosphate-buffered saline buffer.
Scoring method
Quantitative analysis was performed with an image cytometer. d One author (PR) scored AgNORs and MIB1 immunohistochemistry and another (GS) counted mitoses.
AgNORs. Quantitative evaluation of interphase AgNORs was performed by measuring the area (m 2 ) occupied by AgNOR dots (AgNOR area). Every image was obtained with the 40ϫ objective. One hundred neoplastic cells and 10 fibroblasts or lymphocytes were evaluated for each tumor. To compensate for staining variability in differently processed samples, the AgNOR area of tumor cells was compared with the AgNOR area of an internal control such as fibroblasts and lymphocytes (AgNOR index was expressed as the ratio between the mean AgNOR area of cancer cells and the mean AgNOR area of internal control). 1 Mitotic index. For each tumor, the observer used a 25ϫ objective to select 10 fields in the most mitotically active areas of the section. In each field inflammatory or stromal cells were erased with an electronic eraser, and using a red (630/10 nm) e bandpass filter, the total nuclear area of only the neoplastic cells was mapped and the number of mitoses was counted. The total number of cells in the 10 fields was assessed by dividing the total nuclear area of the fields by the mean area of a nucleus. Mitotic index was expressed as the number of mitoses per 1,000 neoplastic cells ([total number of mitoses in 10 digitized fields/total number of cells in 10 digitized fields] ϫ 1,000).
MIB1 index. For each tumor, the observer used a 25ϫ objective to select 10 fields with the highest MIB1 positivity. In each field, the first image was mapped with a green (575/ 10 nm) bandpass filter, e and a second area consisting of all the MIB1-positive nuclei was mapped with a blue (490/10 nm) bandpass filter. e In each field, inflammatory or stromal cells were erased. MIB1 index was calculated as the percentage of labeled nuclei compared with the total nuclear area ([total nuclear area of positively stained nuclei in 10 digitized fields/total nuclear area in 10 digitized fields] ϫ 100).
Statistical analysis
Statistical analyses were performed as previously described 17 using 2 different software packages. f,g Mitotic index, MIB1 index, and AgNOR index were tested for normality with the Shapiro-Wilks W-test. Because the W-test revealed no significant results for all parameters analyzed, all the variables were considered normally distributed. An analysis of variance (ANOVA) was performed to compare the proliferative activity among groups with different histologic stages. According to mean values of proliferation indexes, dogs were divided into low-and high-proliferativeactivity groups, and their survival curves were computed using the Kaplan-Meier estimate and compared by survival analysis. Risk analysis was conducted as previously described. 17 The significance level for each risk factor was tested with the chi-square test (Yates correction).
The analysis of survival as a function of the other variables was performed by multiple nonlinear logistic regression. This choice was motivated by the discrete character of the survivor variable (0,1), which can be described by a multivariate logistic function of the form 3 , and x 4 are the histologic stage, AgNOR index, mitotic activity, and MIB1 index, respectively. In this analysis the absolute value of a i is related to the significance of the considered variables. The fit procedure was accomplished by nonlinear minimization with the Levenberg-Marquardt method.
Results
The 60 female dogs ranged from 3 to 17 years of age (x Ϯ SD ϭ 10.01 Ϯ 2.43 years; median ϭ 10 years). Twenty were crossbred and 38 were purebred dogs (9 German Shepherd Dogs, 9 Yorkshire Terriers, 3 Groenlanders, 2 Dachshunds, 2 Epagnuel Bretons, and single representatives of other breeds). For 2 dogs, breed was not known.
Histologic diagnosis (staging) included 18 tubular adenocarcinomas (6 stage 0 and 12 stage I), 13 papillary-cystic adenocarcinomas (7 stage 0, 5 stage I, and 1 stage II), 11 malignant mixed tumors (3 stage 0, 6 stage I, and 2 stage II), 12 solid carcinomas (6 stage I and 6 stage II), 4 scirrhous carcinomas (1 stage 0 and 3 stage I), 1 spindle-cell carcinoma (stage II), and 1 squamous carcinoma (stage I), for a total of 17 stage 0, 33 stage I, and 10 stage II tumors (Table 1) .
At 24 months after mastectomy, 46 of the 60 dogs were alive and 14 were dead (6 were euthanized and 8 died spontaneously because of tumor spread). Diagnosis, histologic stage, survival (in a 2-year followup), type of death (spontaneous or by euthanasia), and values for mitotic index, MIB1 index, and AgNOR index are given in Table 1 .
Toluidine blue stain made the recognition of mitoses easier than did hematoxylin and eosin stain because of chromatin condensation. MIB1-positive reaction was expressed as a granular nuclear staining often with a prominent nucleolar positivity ( Fig. 1 ). Of the 60 tumors stained with MIB1, only 45 had positive staining; 15 were discarded because they had no reaction to MIB1. The standardized AgNOR method revealed in all processed specimens an excellent staining quality of AgNOR which appeared as black dots of different shape and size, scattered in the light nuclear background (Fig. 2) . Figure 3 shows survival curves in a 2-year follow-up period of dogs grouped by tumor stage (HSt) according to criteria previously established. 14 Comparison of the curves by the log-rank test revealed a significant difference in survival time in all comparisons except HSt0 versus HSt1 (HSt0 vs. HStI, P ϭ 0.45; HSt0 vs. HStII, P ϭ 0.031; HStI vs. HStII, P ϭ 0.019). The significant difference in survival time for stages 0 and 1 versus stage II was also confirmed by risk analysis, which demonstrated a 10-fold increased probability of survival for dogs with stage I or stage 0 tumors compared with those with stage II tumors 12 months postmastectomy and a 5-fold increased probability of survival at 24 months postmastectomy. Mitotic index and MIB1 index revealed a significant difference (ANOVA, P Ͻ 0.001 for both indexes) among the 3 different histologic stages (HSt0 vs. HStI vs. HStII) ( Table 2) .
To test the prognostic role of the proliferative indices employed, values were divided into 2 groups according to their mean value, designated as having low (values Յ mean) or high (values Ͼ mean) proliferative activity. Values were then compared by survival analysis. Mean values were 6.02 for mitotic index, 6.97 for MIB1 index, and 3.09 for AgNOR index. Survival curves compared with the log-rank test revealed a significant difference between high and low proliferative activity groups for AgNOR and MIB1 indexes (P ϭ 0.0015 for AgNOR; P ϭ 0.014 for MIB1) (Figs. 4, 6) ; only mitotic index did not appear useful for prognostic purposes (P ϭ 0.39) ( Fig. 5 ). Risk analysis confirmed the correlation between AgNOR and MIB1 indexes and survival. Both parameters revealed a significantly lower proportional risk in the group with high proliferative activity compared with the group with low activity at 12 and 24 months postmastectomy.
A nonlinear multivariate logistic regression was performed to test the combined influence on survival of the parameters evaluated in the univariate analysis. The nonlinear multivariate logistic regression test revealed, as judged by univariate analysis, the prominent but differently weighted roles of histologic stage and AgNOR index on survival at 12 and 24 months; AgNOR had a stronger influence on survival at 12 months and histologic stage had a stronger influence at 24 months postmastectomy (at 12 months: 0.85 for histologic stage, 0.61 for mitotic index, 1.01 for MIB1 index, 1.06 for AgNOR index; at 24 months: 63.00 for histologic stage, 16.07 for mitotic index, 16.28 for MIB1 index, 33.03 for AgNOR index).
Discussion
Determining the prognosis of a canine patient with a malignant mammary tumor is very important for the clinician, but it is often difficult because the biologic behavior of these tumors varies widely. The major challenge is to find those prognostic variables that allow the prediction of disease behavior in the individual case. Much information could be gained by defining groups of patients with a distinct pattern of survival. 18 Among the different clinical and histologic variables, tumor size and histologic stage have demonstrated an undoubted value in prognosis. 30 Moreover, the histologic stage has shown an independent and more significant prognostic value than has tumor size; survival time is not influenced by tumor size in malignant tumors with neoplastic emboli in vessels (stage II). 18 Histologic type is considered less important than size and stage as a prognostic parameter. 18, 24, 26 Although sarcomas have a poorer prognosis than simple carcinomas and simple carcinomas have a poorer prognosis than complex carcinomas, the lymph node involvement is more important than the histologic type, confirming the higher influence of invasion on survival. 26 The question of histogenesis of tumors in the mammary gland is still debated. Many dysplastic and tumor lesions probably originate from stem cells situated in the terminal duct-lobular units, although some authors 3, 12 have emphasized the poorer prognosis of ductular carcinomas.
In the present study, results of survival and risk analyses support the prognostic significance of histo- logic stage, as reported previously. 2 Nevertheless, the evaluation of histologic invasiveness may sometimes be uncertain, mainly because detection of the neoplastic emboli in the histologic section is not always possible when these emboli are very rare. Moreover, the histologic staging of tumors with neoplastic emboli in vessels (stage II) needs a clinical confirmation by an echographic or radiographic examination to exclude the presence of distant gross metastases even if it is not possible to exclude the presence of micrometastases.
The aim of this study was to improve the prognostic information gained by histologic staging by the association with the evaluation of different proliferation markers (mitotic index, AgNOR index, and MIB1 index) to predict the biologic behavior of malignant canine mammary tumors. The use of the monoclonal antibody Ki67 on fresh tissues and of the clone MIB1 on formalin-fixed material and of antibodies against PCNA is widely applied for the detection of cycling cells. PCNA immunohistochemistry is more difficult to standardize than is Ki67 immunohistochemistry on the basis of dilution and signal intensity. An increasing amount of PCNA-positive cells has been demonstrated when using increasing concentrations of the monoclonal antibody PC10, 23 whereas a clear plateau of positive cells is encountered for a wide range of dilutions with MIB1. 33 Moreover, the antibodies against PCNA stain almost all nuclei in different tissues after microwave irradiation. In contrast, MIB1 only stains the nuclei of cells known to be cycling; quiescent cells are consistently negative. 13 Thus, after antigen retrieval, only MIB1 can be used as a reliable proliferation marker in routinely fixed and processed tissues, even if stored material sometimes may be nonreactive because prolonged fixation has destroyed the antigen. In this investigation, only 45 of 60 tumors had positive staining; 15 were discarded because they had no reaction to MIB1.
The employment of the standardized AgNOR staining protocol 1,25 is necessary for obtaining sound results in paraffin-embedded sections. Nevertheless, only a single article about the standardized AgNOR method and canine mammary tumors currently exists in the veterinary literature. 21 Lack of staining standardization makes the comparison of results difficult between different studies of AgNORs in canine mammary tumors. 6, 7, 10 Based on the mean values of the mitotic index and the MIB1 index, a significant difference in proliferation was observed among the different histologic stages. These results suggest a close relationship between the growth fraction expressed by the mitotic and MIB1 indexes and the infiltrative growth graded as histologic invasiveness (histologic stage). AgNOR quantitation was not as important as the mitotic index and the MIB1 index because it is strictly related to cell duplication rate 9 and does not allow the evaluation of the number (state) of cycling cells, as do the other parameters.
In this study, the prognostic relevance was limited to the AgNOR and MIB1 indexes, as in previous investigations. 6, 21, 27 AgNOR quantity and MIB1 index have demonstrated a prognostic value, but it is difficult to prove that their prognostic information is more useful than that provided by an easily quantified histologic variable such as invasiveness. Therefore, the combined influence of histologic stage, MIB1 index, and Ag-NOR index on survival time was tested by the nonlinear logistic multiple regression, and the prominent role of histologic stage and AgNOR index was demonstrated. Moreover, the higher prognostic sensitivity of the AgNOR index compared with histologic invasiveness for survival at 12 months may be because interphase AgNOR quantity is only related to the rate of cell duplication; the more rapid the cell proliferation, the greater the quantity of interphase AgNORs. 31 High values for the cell proliferation rate are related to the more rapid progression of the disease, and these data indicate that the AgNOR index is very useful for predicting the clinical outcome of tumors showing a more aggressive behavior. On the contrary, the histologic stage was the most reliable prognostic parameter at 24 months postmastectomy (i.e., for a longer period with respect to AgNOR) probably because invasiveness increases its influence when that of AgNOR has receded. In this situation, the progression of neoplastic disease is more influenced by other prognostic features such as vessel invasion or lymph node involvement. All these data support the importance of the information provided by histologic stage and AgNOR index for predicting postsurgical outcome in malignant canine mammary tumors. The integration of these variables is prognostically relevant and can be very useful for formulating a categorized system allowing a reliable prediction of disease behavior in individual cases. 
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